- Home
- TOUR vs INMB Comparison
TOUR vs INMB Comparison
Compare TOUR & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOUR
- INMB
- Stock Information
- Founded
- TOUR 2006
- INMB 2015
- Country
- TOUR China
- INMB United States
- Employees
- TOUR N/A
- INMB N/A
- Industry
- TOUR Transportation Services
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- TOUR Consumer Discretionary
- INMB Health Care
- Exchange
- TOUR Nasdaq
- INMB Nasdaq
- Market Cap
- TOUR 117.7M
- INMB 103.1M
- IPO Year
- TOUR 2014
- INMB 2019
- Fundamental
- Price
- TOUR $1.00
- INMB $6.45
- Analyst Decision
- TOUR
- INMB Strong Buy
- Analyst Count
- TOUR 0
- INMB 2
- Target Price
- TOUR N/A
- INMB $21.00
- AVG Volume (30 Days)
- TOUR 162.3K
- INMB 377.7K
- Earning Date
- TOUR 03-12-2025
- INMB 10-31-2024
- Dividend Yield
- TOUR N/A
- INMB N/A
- EPS Growth
- TOUR N/A
- INMB N/A
- EPS
- TOUR N/A
- INMB N/A
- Revenue
- TOUR $72,825,718.00
- INMB $42,000.00
- Revenue This Year
- TOUR $20.26
- INMB N/A
- Revenue Next Year
- TOUR $15.73
- INMB N/A
- P/E Ratio
- TOUR N/A
- INMB N/A
- Revenue Growth
- TOUR 38.57
- INMB N/A
- 52 Week Low
- TOUR $0.59
- INMB $4.32
- 52 Week High
- TOUR $1.76
- INMB $14.74
- Technical
- Relative Strength Index (RSI)
- TOUR 48.92
- INMB 63.48
- Support Level
- TOUR $0.93
- INMB $5.82
- Resistance Level
- TOUR $1.05
- INMB $6.83
- Average True Range (ATR)
- TOUR 0.05
- INMB 0.55
- MACD
- TOUR 0.00
- INMB 0.18
- Stochastic Oscillator
- TOUR 60.00
- INMB 83.61
About TOUR Tuniu Corporation
Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. All the company's revenues are derived from within the People's Republic of China.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.